Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Keeping Track: US FDA Clears Novel Flu Treatment Xofluza, Boosts Trintellix Label With Sexual Dysfunction Data

Oct 29 2018

• By Bridget Silverman

Keeping Track Feature image

Related Content

Keeping Track: Xarelto Earns CV Risk Reduction Claim In Quiet Week; Spotlight On Formal Dispute Resolution

Oct 14 2018

Keeping Track: A Long-Awaited Approval For Generic EpiPen, Cancer Product Labels Expand And Constrict

Aug 19 2018

Roche Registers Fresh Win For New Flu Drug

Oct 04 2018

Related Companies

Shionogi & Co. Ltd.

Roche Holding AG

Takeda Pharmaceutical Co. Ltd.

H. Lundbeck A/S

Novo Nordisk A/S

Regeneron Pharmaceuticals, Inc.

Genentech, Inc.

Additional Topics

United States Approvals Drug Review Regulation BioPharmaceutical

More from Approvals

More from Product Reviews

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window